From: French “real life” experience of clofarabine in children with refractory or relapsed acute lymphoblastic leukaemia
MRD evolution
Number (%)
Improvement of one logarithm
1 (12.5%)
Improvement of less than one logarithm
3 (37.5%)
Stable
Non evaluable